Review: Low-molecular-weight heparin may be as effective and safe as vitamin-K antagonists in symptomatic venous thromboembolism
John T. Philbrick
Abstract
John T. Philbrick
Abstract
Source Citation van der Heijden JF, Hutten BA, Büller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2000;(4):CD002001 (latest version 28 Mar 2000). 11034739
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Source Citation van der Heijden JF, Hutten BA, Büller HR, Prins MH. Vitamin K antagonists or low-molecular-weight heparin for the long term treatment of symptomatic venous thromboembolism. Cochrane Database Syst Rev. 2000;(4):CD002001 (latest version 28 Mar 2000). 11034739
Key concepts: Medicine, Venous thromboembolism, Vitamin k, Low molecular weight heparin, Heparin, Internal medicine, Gastroenterology, Thrombosis